Dupuytren disease: An update on recent literature

Current Orthopaedic Practice

Volumn 19, Issue 5, 2008, Pages 499-502

  Caufield, Ryan J ^a   Edwards, Scott G ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Collagenase; Cytokines; Dupuytren's; Fasciotomy; Needle

Indexed keywords

COLLAGENASE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA;

CLINICAL TRIAL; DISEASE COURSE; DUPUYTREN CONTRACTURE; ECCHYMOSIS; EDEMA; FASCIOTOMY; HUMAN; INJECTION PAIN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 55249121929     PISSN: 19407041     EISSN: 19417551     Source Type: Journal    
DOI: 10.1097/BCO.0b013e3283025e78     Document Type: Review

References (33)

1. Eliot D. The early history of Dupuytren's disease. Hand Clin. 1999; 15:1-19.
2. Cline H. Notes on pathology. London: St. Thomas's Hospital Medical School Library; 1777:185.
3. Thurston AJ. Dupuytren's disease. J Bone Joint Surg Br. 2003; 85:469-477.
4. Benson LS, Williams CS, Kahle M. Dupuytren's contracture. J Am Acad Orthop Surg. 1998; 6:24-35.
5. McGrouther DA. Dupuytren's Contracture. In: Green DP, et al., editors. Greens's operative hand surgery, 5th ed. Philadelphia:Elsevier; 2005. pp. 159-185.
6. Rayan GM. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg. 2007; 89:190-198. Excellent review of the anatomy, pathology, presentation, and treatment of Dupuytren's disease.
7. Hindocha S, John S, Stanley JK, et al. The heritability of Dupuytren's disease: familial aggregation and its clinical significance. J Hand Surg Am. 2006; 31:204-210.
8. Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet. 2005; 68:424-429.
9. Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg Br. 1999; 24:456-459.
10. Arkkila PE, Kantola IM, Viikari JS. Dupuytren's disease: association with chronic diabetic complications. J Rheumatol. 1997; 24:153-159.
11. Burke FD, Proud G, Lawson IJ, et al. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren's disease in 97,537 miners. J Hand Surg Br. 2007; 32:400-406. The study assesses the effect of exposure to vibration, smoking, diabetes, and alcohol on the prevalence of Dupuytren's disease.
12. Elhadd TA, Ghosh S, Malik MI, et al. Plantar fibromatosis and Dupuytren's disease: an association to remember in patients with diabetes. Diabet Med. 2007; 24:1305.
13. Burge P, Hoy G, Regan P, et al. Smoking, alcohol and the risk of Dupuytren's contracture. J Bone Joint Surg Br. 1997; 79:206-210.
14. Al-Qattan MM. Factors in the pathogenesis of Dupuytren's contracture. J Hand Surg Am. 2006; 31:1527-1534.
15. Lucas G, Brichet A, Roquelaure Y, et al. Dupuytren's disease: personal factors and occupational exposure. Am J Ind Med. 2008; 51:9-15. Finds manual work exposure was associated with Dupuytren's disease after adjustment for personal risk factors.
16. Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg Am. 2005; 30:1021-1025.
17. Dias JJ, Braybrooke J. Dupuytren's contracture: an audit of the outcomes of surgery. J Hand Surg Br. 2006; 31:514-521.
18. Badalamente MA, Hurst LC. The biochemistry of Dupuytren's disease. Hand Clin. 1999; 15:35-42.
19. Augoff K, Kula J, Gosk J, et al. Epidermal growth factor in Dupuytren's disease. Plast Reconstr Surg. 2005; 115:128-133.
20. Cordova A, Tripoli M, Corradino B, et al. Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives. J Hand Surg Br. 2005; 30:557-562.
21. Ulrich D, Hrynyschyn K, Pallua N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Plast Reconstr Surg. 2003; 112:1279-1286.
22. Johnston P, Chojnowski AJ, Davidson RK, et al. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease. J Hand Surg Am. 2007; 32:343-351. The study examines the expression of key enzymes in collagen turnover in Dupuytren's tissue.
23. Augoff A, Ratajczak K, Gosk J, et al. Gelatinase A activity in Dupuytren's disease. J Hand Surg Am. 2006; 31:1635-1639.
24. Bowley E, O'Gorman DB, Gan BS, et al. β-Catenin signaling in fibroproliferative disease. J Surg Res. 2007; 138:141-150. The study highlights the current knowledge of β-catenin signaling in fibroproliferative disease.
25. Lee LC, Zhang AY, Chong AK, et al. Expression of a novel gene, MafB, in Dupuytren's disease. J Hand Surg Am. 2006; 31:211-218.
26. Lubahn JD, Pollard M, Cooney T. Immunohistochemical evidence of nerve growth factor in Dupuytren's diseased palmar fascia. J Hand Surg Am. 2007; 32:337-342. The study demonstrates elevated levels of nerve growth factor in tissue affected by Dupuytren's disease.
27. Lermusiaux JL, Debeyre N. Le traitment medical de la maladie de Dupuytren. In: de Seze S, Ryckewaert A, Kahn M-F, Guerin CI, editors. L'actualite rhumatologique. Paris:Expansion Scientifique Francaise; 1980. pp. 338-343.
28. Van Rijssen AL, Werker PMN. Percutaneous needle fasciotomy in Dupuytren's disease. J Hand Surg Br. 2006; 31:498-501.
29. Van Rijssen AL, Gerbrandy FSJ, Linden HT, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006; 31:717-725.
30. Hurst LC, Badalamente MA. Nonoperative treatment of Dupuytren's disease. Hand Clin. 1999; 15:97-107.
31. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am. 2000; 25:629-636.
32. Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002; 27:788-798.
33. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007; 32:767-774. The study presents the results of a phase III double-blind, placebo-controlled trial evaluating the efficacy of collagenase injection therapy for Dupuytren contracture.